Leader of Duke Cancer Institute’s Endocrine Neoplasia Diseases Group and chief of Endocrine Surgery, Julie Ann Sosa, MD, MA, FACS, has been named Woman of the Year in Thyroidology by the American Thyroid Association (ATA).
The annual Woman of the Year award is based on the awardee’s long-standing commitment to the ATA and to the advancement of women both within the organization and in the thyroid field.
“We are extremely grateful for your contributions and your sustained commitment to our various initiatives,” wrote Honey V. Reddi, PhD, president of the ATA’s Women in Thyroidology group, in an email. “This award is a small recognition of these efforts.”
Sosa was also awarded the association’s Lewis E. Braverman Distinguished Lectureship Award, which recognizes the individual who has demonstrated excellence and passion for mentoring fellows, students and junior faculty; has a long history of productive thyroid research; and is devoted to the ATA.
Sosa received the awards and delivered the lecture on October 19 during the 87th Annual Meeting of the American Thyroid Association in Victoria, Canada.
“I’m really proud of having been selected to receive the two awards, as I was nominated for them by colleagues and mentees,” said Sosa, who has mentored more than 50 students, residents and fellows, particularly around health services research in surgery, thyroidology, and oncology. “I’m so proud of all my mentees; indeed, many already have gone on to become thought leaders themselves. They will be my legacy as much – if not more – than my science!”
The title of Sosa’s talk for the endowed lectureship was “Re-telling the Story About Thyroid Cancer: Rising Incidence, Mortality, and Maybe an Explanation.”
“I reviewed the evolving understanding of the epidemiology of thyroid cancer, informed by our recent study, with the National Cancer Institute, that was published in JAMA (Lim et al, 2017), as well new data suggesting there might be an association between thyroid cancer and exposures to flame retardants in the home, informed by our recent study (with Duke environmental researcher Heather Stapleton, PhD, funded by a Cancer and the Environment grant from Duke Cancer Institute) that was published in Environment International (Hoffman et al, 2017),” said Sosa.
In addition to the Endocrine Neoplasia Diseases Group, Sosa leads the Surgical Center for Outcomes Research (SCORES) and co-leads Duke Cancer Institute’s Solid Tumor Therapeutics Program. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer.
Sosa is treasurer of the American Thyroid Association (ATA) and serves on the Board of Directors/Executive Council of the ATA, International Thyroid Oncology Group, and Society for Surgical Oncology, as well as practice guidelines committees for the ATA and the NCCN. She is an NIH-funded investigator and author of 270 peer-reviewed publications and 50 book chapters, largely focused on outcomes research, health care delivery, hyperparathyroidism, and thyroid cancer, with a focus on clinical trials. Sosa is also deputy editor of JAMA-Surgery and incoming editor-in-chief of World Journal of Surgery.